{"id":"https://openalex.org/W4409704743","doi":"https://doi.org/10.1007/s11864-025-01317-5","title":"PSMA-based Therapies and Novel Therapies in Advanced Prostate Cancer: The Now and the Future","display_name":"PSMA-based Therapies and Novel Therapies in Advanced Prostate Cancer: The Now and the Future","alternate_titles":[],"publication_year":2025,"publication_date":"2025-04-23","ids":{"openalex":"https://openalex.org/W4409704743","doi":"https://doi.org/10.1007/s11864-025-01317-5","pmid":"https://pubmed.ncbi.nlm.nih.gov/40266437","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/12055665"},"language":"en","primary_location":{"id":"doi:10.1007/s11864-025-01317-5","doi":"https://doi.org/10.1007/s11864-025-01317-5","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s11864-025-01317-5","pdf_url":"https://link.springer.com/content/pdf/10.1007/s11864-025-01317-5.pdf","source":{"id":"https://openalex.org/S208090617","display_name":"Current Treatment Options in Oncology","issn_l":"1534-6277","issn":["1534-6277","1527-2729"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Treatment Options in Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4409704743"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s11864-025-01317-5.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111332421","display_name":"Ann Ayzman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ann Ayzman","raw_affiliation_strings":["Department of Internal Medicine, Washington University in St. Louis, 660 S. Euclid Ave, Campus, Box 8056, St. Louis, MO, 63110, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Washington University in St. Louis, 660 S. Euclid Ave, Campus, Box 8056, St. Louis, MO, 63110, USA","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083027775","display_name":"Russell Kent Pachynski","orcid":"https://orcid.org/0000-0002-8966-7631","observed_orcids":["https://orcid.org/0000-0002-8966-7631"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Russell K. Pachynski","raw_affiliation_strings":["Division of Medical Oncology, Department of Internal Medicine, Washington University in St. Louis, 660 S. Euclid Ave, Campus, Box 8056, St. Louis, MO, 63110, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Department of Internal Medicine, Washington University in St. Louis, 660 S. Euclid Ave, Campus, Box 8056, St. Louis, MO, 63110, USA","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033671689","display_name":"Melissa Andrea Reimers","orcid":"https://orcid.org/0000-0002-5167-3630","observed_orcids":["https://orcid.org/0000-0002-5167-3630"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Melissa A. Reimers","raw_affiliation_strings":["Division of Medical Oncology, Department of Internal Medicine, Washington University in St. Louis, 660 S. Euclid Ave, Campus, Box 8056, St. Louis, MO, 63110, USA. mreimers@wustl.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Department of Internal Medicine, Washington University in St. Louis, 660 S. Euclid Ave, Campus, Box 8056, St. Louis, MO, 63110, USA. mreimers@wustl.edu","institution_ids":["https://openalex.org/I204465549"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5033671689"],"corresponding_institution_ids":["https://openalex.org/I204465549"],"apc_list":{"value":4890,"currency":"USD","value_usd":4890},"apc_paid":{"value":4890,"currency":"USD","value_usd":4890},"fwci":1.6688,"has_fulltext":true,"cited_by_count":24,"citation_normalized_percentile":{"value":0.8485,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":97,"max":100},"biblio":{"volume":"26","issue":"5","first_page":"375","last_page":"384"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9297000169754028,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9297000169754028,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.05469999834895134,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":0.007600000128149986,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-castration-resistant-prostate-cancer","display_name":"metastatic castration-resistant prostate cancer","score":0.9509999752044678},{"id":"https://openalex.org/keywords/psma-radioligand-therapy","display_name":"PSMA radioligand therapy","score":0.9649999737739563},{"id":"https://openalex.org/keywords/177lu-lu-psma-617","display_name":"177Lu-PSMA-617","score":0.9490000009536743},{"id":"https://openalex.org/keywords/bispecific-t-cell-engagers","display_name":"bispecific T-cell engagers","score":0.9990000128746033},{"id":"https://openalex.org/keywords/tumor-heterogeneity","display_name":"tumor heterogeneity","score":0.7379999756813049},{"id":"https://openalex.org/keywords/treatment-resistance","display_name":"treatment resistance","score":0.6200000047683716},{"id":"https://openalex.org/keywords/immune-related-toxicity","display_name":"immune-related toxicity","score":0.7279999852180481},{"id":"https://openalex.org/keywords/cytokine-release-syndrome","display_name":"cytokine release syndrome","score":0.8450000286102295},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.7260000109672546},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.7170000076293945},{"id":"https://openalex.org/keywords/radiation-protection","display_name":"radiation protection","score":0.7160000205039978},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.6140000224113464},{"id":"https://openalex.org/keywords/hormone-sensitive-prostate-cancer","display_name":"hormone-sensitive prostate cancer","score":0.7129999995231628},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.8709999918937683},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.625}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9598753452301025},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.8084022998809814},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5144162774085999},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4152463972568512},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3447531759738922},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3284831643104553}],"mesh":[{"descriptor_ui":"D000954","descriptor_name":"Antigens, Surface","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019275","descriptor_name":"Radiopharmaceuticals","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D043425","descriptor_name":"Glutamate Carboxypeptidase II","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D043425","descriptor_name":"Glutamate Carboxypeptidase II","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059016","descriptor_name":"Tumor Microenvironment","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D064129","descriptor_name":"Prostatic Neoplasms, Castration-Resistant","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D064129","descriptor_name":"Prostatic Neoplasms, Castration-Resistant","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D064129","descriptor_name":"Prostatic Neoplasms, Castration-Resistant","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1007/s11864-025-01317-5","doi":"https://doi.org/10.1007/s11864-025-01317-5","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s11864-025-01317-5","pdf_url":"https://link.springer.com/content/pdf/10.1007/s11864-025-01317-5.pdf","source":{"id":"https://openalex.org/S208090617","display_name":"Current Treatment Options in Oncology","issn_l":"1534-6277","issn":["1534-6277","1527-2729"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Treatment Options in Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:12055665","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12055665/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12055665/pdf/11864_2025_Article_1317.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Curr Treat Options Oncol","raw_type":"Text"},{"id":"pmh:oai:europepmc.org:10868352","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/12055665","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:40266437","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40266437","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current treatment options in oncology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1007/s11864-025-01317-5","doi":"https://doi.org/10.1007/s11864-025-01317-5","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s11864-025-01317-5","pdf_url":"https://link.springer.com/content/pdf/10.1007/s11864-025-01317-5.pdf","source":{"id":"https://openalex.org/S208090617","display_name":"Current Treatment Options in Oncology","issn_l":"1534-6277","issn":["1534-6277","1527-2729"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Treatment Options in Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4409704743.pdf","grobid_xml":"https://content.openalex.org/works/W4409704743.grobid-xml"},"referenced_works_count":42,"referenced_works":["https://openalex.org/W2006664751","https://openalex.org/W2021850762","https://openalex.org/W2343936933","https://openalex.org/W2467018059","https://openalex.org/W2606187374","https://openalex.org/W2886366369","https://openalex.org/W2982970399","https://openalex.org/W3033684926","https://openalex.org/W3104647211","https://openalex.org/W3146533240","https://openalex.org/W3164241359","https://openalex.org/W3164738465","https://openalex.org/W3172787303","https://openalex.org/W3176208875","https://openalex.org/W3193639601","https://openalex.org/W4213004412","https://openalex.org/W4306293700","https://openalex.org/W4328095977","https://openalex.org/W4378800385","https://openalex.org/W4379281637","https://openalex.org/W4380789988","https://openalex.org/W4382361627","https://openalex.org/W4387798677","https://openalex.org/W4387810272","https://openalex.org/W4388089396","https://openalex.org/W4388284228","https://openalex.org/W4389828735","https://openalex.org/W4390640719","https://openalex.org/W4390721999","https://openalex.org/W4391303171","https://openalex.org/W4391451267","https://openalex.org/W4394770818","https://openalex.org/W4395453742","https://openalex.org/W4396529780","https://openalex.org/W4399178517","https://openalex.org/W4399324593","https://openalex.org/W4399394744","https://openalex.org/W4399980266","https://openalex.org/W4400414544","https://openalex.org/W4401715535","https://openalex.org/W4402552580","https://openalex.org/W4402565848"],"related_works":["https://openalex.org/W4362705641","https://openalex.org/W7141165881","https://openalex.org/W3095574415","https://openalex.org/W3000208382","https://openalex.org/W7167742857","https://openalex.org/W4410876561","https://openalex.org/W2794578219","https://openalex.org/W7163186988","https://openalex.org/W3048833320","https://openalex.org/W3181663023"],"abstract_inverted_index":{"OPINION":[0],"STATEMENT:":[1],"The":[2,153,229],"treatment":[3,163,257],"landscape":[4],"for":[5,33],"metastatic":[6,166],"castration-resistant":[7],"prostate":[8,167],"cancer":[9],"(mCRPC)":[10],"is":[11],"rapidly":[12],"evolving":[13],"with":[14,132,234],"the":[15,62,67,114,137,145,171,253],"advent":[16],"of":[17,70,76,84,117,139,147,173,196,232,255],"PSMA-targeted":[18],"radioligand":[19],"therapies":[20,72,189,272],"(RLTs)":[21],"and":[22,61,150,211,222,238,270,281,293],"bispecific":[23],"T-cell":[24,199],"engagers":[25],"(BiTEs).":[26],"These":[27],"novel":[28],"approaches":[29],"provide":[30],"new":[31],"hope":[32],"patients":[34,131],"who":[35],"have":[36,125],"progressed":[37],"on":[38],"standard":[39,172],"therapies.":[40],"However,":[41,136],"their":[42,100,185],"full":[43],"clinical":[44,96,186],"potential":[45,230],"will":[46,284],"be":[47,109,243,285],"realized":[48],"only":[49],"by":[50],"addressing":[51],"key":[52],"challenges,":[53],"including":[54],"tumor":[55,64,203,239],"heterogeneity,":[56],"resistance":[57,292],"mechanisms,":[58],"immune-related":[59],"toxicities,":[60],"immunosuppressive":[63],"microenvironment.":[65],"Additionally,":[66],"optimal":[68],"sequencing":[69],"these":[71,85,251],"at":[73,273],"different":[74,192],"stages":[75],"disease":[77,104,275],"remains":[78],"an":[79,161],"open":[80],"question.":[81],"While":[82,206],"most":[83],"interventions":[86],"are":[87,98,226],"currently":[88],"introduced":[89],"in":[90,102,112,130,164,183,260,287],"late-stage,":[91],"heavily":[92],"pretreated":[93],"patients,":[94],"ongoing":[95,154],"trials":[97],"exploring":[99],"role":[101],"earlier":[103,274],"settings,":[105],"where":[106],"they":[107],"may":[108,157,181],"more":[110],"effective":[111],"altering":[113],"natural":[115],"history":[116],"disease.":[118],"PSMA-based":[119,267],"RLTs,":[120,268],"such":[121,217],"as":[122,160,218],"177Lu-PSMA-":[123],"617,":[124],"demonstrated":[126],"promising":[127],"efficacy,":[128],"particularly":[129],"high":[133],"PSMA":[134],"expression.":[135],"presence":[138],"PSMA-negative":[140],"or":[141],"heterogeneous":[142],"tumors":[143],"necessitates":[144],"development":[146],"additional":[148],"biomarkers":[149],"combination":[151,282],"strategies.":[152],"PSMAddition":[155],"trial":[156],"establish":[158],"RLTs":[159],"earlier-line":[162],"hormone-sensitive":[165],"cancer,":[168],"potentially":[169],"shifting":[170],"care.":[174],"Moreover,":[175],"mitigating":[176],"toxicities":[177],"through":[178],"radioprotective":[179],"agents":[180,241],"aid":[182],"expanding":[184],"utility.":[187],"BiTE":[188],"offer":[190],"a":[191,261],"but":[193],"complementary":[194,271],"mechanism":[195],"action,":[197],"leveraging":[198],"engagement":[200],"to":[201,246],"drive":[202],"cell":[204],"destruction.":[205],"cytokine":[207],"release":[208],"syndrome":[209],"(CRS)":[210],"immunogenicity":[212],"remain":[213],"significant":[214],"hurdles,":[215],"modifications":[216],"low-affinity":[219],"CD3":[220],"binding":[221],"optimized":[223],"dosing":[224],"regimens":[225,283],"showing":[227],"promise.":[228],"synergy":[231],"BiTEs":[233],"immune":[235],"checkpoint":[236],"inhibitors":[237],"microenvironment-modulating":[240],"should":[242],"further":[244],"explored":[245],"enhance":[247],"therapeutic":[248],"efficacy.":[249],"Given":[250],"advancements,":[252],"future":[254],"mCRPC":[256],"likely":[258],"lies":[259],"personalized,":[262],"multimodal":[263],"approach":[264],"that":[265],"integrates":[266],"BiTEs,":[269],"stages.":[276],"Strategic":[277],"biomarker-driven":[278],"patient":[279],"selection":[280],"essential":[286],"optimizing":[288],"outcomes":[289],"while":[290],"minimizing":[291],"toxicity.":[294]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4409704743","counts_by_year":[{"year":2026,"cited_by_count":19},{"year":2025,"cited_by_count":5}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2025-04-24T00:00:00"}
